PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Lady Davis Institute of the Jewish General Hospital, 3755 Côte-Sainte-Catherine Road, Montreal, Quebec, H3T 1E2, Canada.\', \'Department of Psychiatry, McGill University, Montreal, Quebec, Canada.\', \'Department of Clinical Psychology, Radboud University, Nijmegen, The Netherlands.\', \'Department of Medical Psychology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.\', \'Centre for Prognosis Research, School of Medicine, Keele University, Keele, Staffordshire, UK.\', \'St. Joseph\'s Health Care, London, Ontario, Canada.\', \'Department of Medicine, McGill University, Montreal, Quebec, Canada.\', \'Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.\', \'Scleroderma Foundation, Michigan Chapter, Southfield, MI, USA.\', \'Scleroderma Society of Ontario, Hamilton, Ontario, Canada.\', \'Department of Medicine, University of Western Ontario, London, Ontario, Canada.\', \'Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.\', \'California School of Professional Psychology/Alliant, Los Angeles, CA, USA.\', \'Toronto Scleroderma Program, Mount Sinai Hospital & Toronto Western Hospital, Toronto, Ontario, Canada.\', \'Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.\', \'Private practice - Nutrition, Milton, Ontario, Canada.\', \'Department of Psychology, Jewish General Hospital, Montreal, Quebec, Canada.\', \'Department of Medicine, Hospital for Special Surgery, New York City, NY, USA.\', \'Department of Medicine, Stanford University, Palo Alto, CA, USA.\', \'Department of Medicine, Palo Alto VA Health Care System, Palo Alto, CA, USA.\', \'Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.\', \'Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.\', \'Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.\', \'NVLE Dutch patient organization for systemic autoimmune diseases, Utrecht, The Netherlands.\', \'Ottawa Scleroderma Support Group, Ottawa, Ontario, Canada.\', \'University of Minho, Braga, Portugal.\', \'Scleroderma Foundation, Los Angeles, CA, USA.\', \'Scleroderma Canada, Hamilton, Ontario, Canada.\', \'Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.\', \'Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.\', \'Faculty of Behavioural and Movement Sciences, VU University, Amsterdam, The Netherlands.\', \'Department of General Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.\', \'School of Kinesiology, University of the Fraser Valley, Chilliwack, British Columbia, Canada.\', \'Faculty of Kinesiology, University of Calgary, Calgary, Alberta, Canada.\', \'Department of Oncology, Cumming School of Medicine, Calgary, Canada.\', \'Department of Psychosocial Resources, Tom Baker Cancer Centre, Alberta Health Services, Calgary, Alberta, Canada.\', \'Department of Psychology, San Diego State University, San Diego, CA, USA.\', \'Joint Doctoral Program in Clinical Psychology, San Diego State University/University of California San Diego, San Diego, CA, USA.\', \'Department of Internal Medicine, University of Texas McGovern School of Medicine, Houston, TX, USA.\', \'Université de Paris, Centre of Research Epidemiology and Statistics (CRESS), Inserm, INRA, Paris, France.\', \'Centre d\'Épidémiologie Clinique, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Hôtel Dieu, Paris, France.\', \'Service de Médecine Interne, Centre de Référence Maladies Autoimmunes Systémiques Rares d\'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.\', \'APHP-CUP, Hôpital Cochin, Université de Paris, F-75014, Paris, France.\', \'Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.\', \'Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, Quebec, Canada.\', \'Lady Davis Institute of the Jewish General Hospital, 3755 Côte-Sainte-Catherine Road, Montreal, Quebec, H3T 1E2, Canada. brett.thombs@mcgill.ca.\', \'Department of Psychiatry, McGill University, Montreal, Quebec, Canada. brett.thombs@mcgill.ca.\', \'Department of Medicine, McGill University, Montreal, Quebec, Canada. brett.thombs@mcgill.ca.\', \'Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada. brett.thombs@mcgill.ca.\', \'Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, Quebec, Canada. brett.thombs@mcgill.ca.\', \'Department of Psychology, McGill University, Montreal, Quebec, Canada. brett.thombs@mcgill.ca.\', \'Department of Educational and Counselling Psychology, McGill University, Montreal, Quebec, Canada. brett.thombs@mcgill.ca.\', \'Biomedical Ethics Unit, McGill University, Montreal, Quebec, Canada. brett.thombs@mcgill.ca.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-021-05827-z
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 34838105
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
?:title
  • The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all